{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:15:22Z","timestamp":1788304522452,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_50","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:33Z","timestamp":1788302073000},"page":"823-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defining the Role of Marginal Zone B Cells in FVIII Inhibitor Development"],"prefix":"10.1007","author":[{"given":"Sungwoong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Naseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montana","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Chanroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Zerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3\u20134","key":"50_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000090930","volume":"115","author":"AL Dunn","year":"2006","unstructured":"Dunn AL, Abshire TC (2006) Current issues in prophylactic therapy for persons with hemophilia. Acta Haematol 115(3\u20134):162\u2013171","journal-title":"Acta Haematol"},{"issue":"1","key":"50_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2008-06-160432","volume":"113","author":"CL Kempton","year":"2009","unstructured":"Kempton CL, White GC (2009) How we treat a hemophilia A patient with a factor VIII inhibitor. Blood 113(1):11\u201317","journal-title":"Blood"},{"issue":"8813","key":"50_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0140-6736(92)90530-G","volume":"340","author":"S Ehrenforth","year":"1992","unstructured":"Ehrenforth S et al (1992) Factor VIII inhibitors in haemophiliacs. Lancet 340(8813):253","journal-title":"Lancet"},{"issue":"7","key":"50_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1538-7836.2004.00802.x","volume":"2","author":"P Lollar","year":"2004","unstructured":"Lollar P (2004) Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX. J Thromb Haemost 2(7):1082\u20131095","journal-title":"J Thromb Haemost"},{"issue":"8793","key":"50_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","volume":"339","author":"S Ehrenforth","year":"1992","unstructured":"Ehrenforth S et al (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 339(8793):594\u2013598","journal-title":"Lancet"},{"issue":"13","key":"50_CR6","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1182\/blood-2007-06-096842","volume":"110","author":"SL Meeks","year":"2007","unstructured":"Meeks SL et al (2007) Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation. Blood 110(13):4234\u20134242","journal-title":"Blood"},{"issue":"10","key":"50_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/j.1538-7836.2004.00944.x","volume":"2","author":"L Aledort","year":"2004","unstructured":"Aledort L (2004) Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2(10):1700\u20131708","journal-title":"J Thromb Haemost"},{"issue":"23","key":"50_CR8","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1182\/blood-2014-05-577643","volume":"124","author":"CL Kempton","year":"2014","unstructured":"Kempton CL, Meeks SL (2014) Toward optimal therapy for inhibitors in hemophilia. Blood 124(23):3365\u20133372","journal-title":"Blood"},{"issue":"1","key":"50_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/imr.12031","volume":"252","author":"RR Ramiscal","year":"2013","unstructured":"Ramiscal RR, Vinuesa CG (2013) T-cell subsets in the germinal center. Immunol Rev 252(1):146\u2013155","journal-title":"Immunol Rev"},{"issue":"3","key":"50_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva NS, Klein U (2015) Dynamics of B cells in germinal centres. Nat Rev Immunol 15(3):137\u2013148","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"50_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4049\/jimmunol.172.2.803","volume":"172","author":"K Attanavanich","year":"2004","unstructured":"Attanavanich K, Kearney JF (2004) Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 172(2):803\u2013811","journal-title":"J Immunol"},{"issue":"7","key":"50_CR12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.4049\/jimmunol.150.7.2737","volume":"150","author":"C Snapper","year":"1993","unstructured":"Snapper C et al (1993) Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol (Baltimore, Md.: 1950) 150(7):2737\u20132745","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"26","key":"50_CR13","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","volume":"337","author":"Group, T.t.R.A.t.P.S.","year":"1997","unstructured":"Group, T.t.R.A.t.P.S. (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337(26):1861\u20131870","journal-title":"N Engl J Med"},{"issue":"2","key":"50_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13(2):118\u2013132","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"50_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5(8):606\u2013616","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"50_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","volume":"27","author":"J-C Weill","year":"2009","unstructured":"Weill J-C, Weller S, Reynaud C-A (2009) Human marginal zone B cells. Annu Rev Immunol 27(1):267\u2013285","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"50_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2249.2002.01953.x","volume":"130","author":"A Zandvoort","year":"2002","unstructured":"Zandvoort A, Timens W (2002) The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 130(1):4\u201311","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"50_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/intimm\/dxh142","volume":"16","author":"AR Ferguson","year":"2004","unstructured":"Ferguson AR, Youd ME, Corley RB (2004) Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16(10):1411\u20131422","journal-title":"Int Immunol"},{"issue":"23","key":"50_CR19","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"11","key":"50_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","volume":"7","author":"A Navarrete","year":"2009","unstructured":"Navarrete A et al (2009) Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A. J Thromb Haemost 7(11):1816\u20131823","journal-title":"J Thromb Haemost"},{"issue":"4","key":"50_CR21","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.4049\/jimmunol.1002106","volume":"186","author":"Y You","year":"2011","unstructured":"You Y et al (2011) Marginal zone B cells regulate antigen capture by marginal zone macrophages. J Immunol 186(4):2172\u20132181","journal-title":"J Immunol"},{"issue":"5","key":"50_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2005.09.013","volume":"23","author":"A Bergtold","year":"2005","unstructured":"Bergtold A et al (2005) Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23(5):503\u2013514","journal-title":"Immunity"},{"issue":"2","key":"50_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1084\/jem.20030684","volume":"198","author":"MC Karlsson","year":"2003","unstructured":"Karlsson MC et al (2003) Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 198(2):333\u2013340","journal-title":"J Exp Med"},{"issue":"7","key":"50_CR24","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI81059","volume":"125","author":"H Li","year":"2015","unstructured":"Li H et al (2015) Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus. J Clin Invest 125(7):2877\u20132890","journal-title":"J Clin Invest"},{"issue":"2","key":"50_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jth.13202","volume":"14","author":"BN Chao","year":"2016","unstructured":"Chao BN et al (2016) Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene. J Thromb Haemost 14(2):346\u2013355","journal-title":"J Thromb Haemost"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:33Z","timestamp":1788302073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_50","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}